On the concept of myasthenic crisis

Journal of Clinical Neuromuscular Disease

Volumn 4, Issue 1, 2002, Pages 40-42

  Bedlack, Richard S ^a   Sanders, Donald B ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

CALCULATION; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; EXTUBATION; HUMAN; INCIDENCE; MEDICAL LITERATURE; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; OUTCOMES RESEARCH; PATIENT CODING; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STANDARDIZATION;

EID: 0036756359     PISSN: 15220443     EISSN: None     Source Type: Journal    
DOI: 10.1097/00131402-200209000-00009     Document Type: Review

References (23)

1. Keesey J. 'Crisis' in myasthenia gravis: an historical perspective. Muscle Nerve 2002;26:1-3.
2. Bedlack RS, Sanders DB. How to handle myasthenic crisis. Postgrad Med 2000;107:211-222.
3. Rieder P, Louis M, Jolliet P, et al. The repeated measurement of vital capacity is a poor predictor of the need for mechanical ventilation in myasthenia gravis. Intensive Care Med 1995;21:663-668.
4. Thomas C, Mayer S, Gungor Y, et al. Myasthenic crisis: clinical features, mortality, complications and risk factors for prolonged intubation. Neurology 1997;48:1253-1260.
5. Berrouschot J, Baumann I, Kalischewski P, et al. Therapy of myasthenic crisis. Crit Care Med 1997;25:1228-1235.
6. Gracey DR, Divertie MB, Howard FM. Mechanical ventilation for respiratory failure in myasthenia gravis. Mayo Clin Proc 1983; 58:597-602.
7. Cohen MS, Younger D. Aspects of the natural history of myasthenia gravis: crisis and death. Ann N Y Acad Sci 1981;377:670-677.
8. Jaretzki A, Barohn R, Ernstoff R, et al. Myasthenia gravis: recommendations for clinical research standards. Neurology 2000;55: 16-23.
9. Oosterhuis HJ. Observations of the natural history of myasthenia gravis and the effect of thymectomy. Ann N Y Acad Sci 1981; 377:678-689.
10. Glaser GH. Crisis, precrisis and drug resistance in myasthenia gravis. Ann N Y Acad Sci 1966;135:335-345.
11. Osserman KE, Genkins G. Studies in myasthenia gravis: reduction in mortality after crisis. JAMA 1963;183:99-101.
12. Osserman KE, Kornfeld P, Cohen E, et al. Studies in myasthenia gravis. Arch Intern Med 1958;102:72-81.
13. Sellman MS, Mayer RF. Treatment of myasthenic crisis in late life. South Med J 1985;78:1208-1210.
14. Simpson JF, Westerberg MR, Magee KR. Myasthenia gravis. Acta Neurol Scand 1966;42:7-27.
15. Tether JE. Management of myasthenic and cholinergic crisis. Am J Med 1955;19:740-742.
16. Jenkins R, Witorsch P, Smyth N. Aspects of treatment of crisis in myasthenia gravis. South Med J 1970;63:1127-1130.
17. Arsura E, Bick A, Brunner N, et al. High-dose intravenous gammaglobulin in the management of myasthenia gravis. Arch Intern Med 1986;146:1365-1368.
18. Cosi V, Lombardi M, Piccolo G, et al. Treatment of myasthenia gravis with high-dose intravenous immunoglobulin. Acta Neurol Scand 1991;84:81-84.
19. Newsom-Davis J, Wilson SC, Vincent A, et al. Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet 1979:1: 464-468.
20. Olarte MR, Schoenfield RS, Penn AS, et al. Effect of plasmapheresis in myasthenia gravis 1978-1980. Ann N Y Acad Sci 1981;377:725-728.
21. Perlo VP, Shahani BT, Huggins CE, et al. Effect of plasmapheresis in myasthenia gravis. Ann N Y Acad Sci 1981;377:709-724.
22. Gorback MS, Moon RE, Massey JM. Extubation after transsternal thymectomy for myasthenia gravis: a prospective analysis. South Med J 1991;84:81-84.
23. Reicin AS, Shapiro D, Sperlings RS, et al. Comparison of cardiovascular thrombotic events in patients with osteoarthritis treated with rofecoxib versus nonselective nonsteroidal anti-inflammatory drugs. Am J Cardiol 2002;89:204-209.